NasdaqCM:MYND

Stock Analysis Report

Executive Summary

MYnd Analytics, Inc. operates as a predictive analytics company primarily in the United States.

Snowflake

Fundamentals

Limited growth with imperfect balance sheet.

Risks

  • MYnd Analytics has significant price volatility in the past 3 months.
  • MYnd Analytics is covered by less than 3 analysts.

Similar Companies

Share Price & News

How has MYnd Analytics's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-17.6%

MYND

0.9%

US Healthcare Services

-0.2%

US Market


1 Year Return

-27.3%

MYND

8.7%

US Healthcare Services

1.1%

US Market

MYND underperformed the Healthcare Services industry which returned 27.1% over the past year.

MYND underperformed the Market in United States of America which returned 4.1% over the past year.


Share holder returns

MYNDIndustryMarket
7 Day-17.6%0.9%-0.2%
30 Day-7.9%-5.2%2.5%
90 Day-4.9%-5.5%1.6%
1 Year-27.3%-27.3%8.8%8.7%3.4%1.1%
3 Year-74.6%-74.6%49.7%49.4%45.2%35.8%
5 Year-97.7%-97.7%50.3%49.4%62.6%44.8%

Price Volatility Vs. Market

How volatile is MYnd Analytics's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is MYnd Analytics undervalued based on future cash flows and its price relative to the stock market?

5.17x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Unable to calculate intrinsic value for MYnd Analytics to establish if it is available at moderate discount.

Unable to calculate intrinsic value for MYnd Analytics to establish if it is available at substantial discount.


Price Based on Earnings

MYnd Analytics is loss making, we can't compare its value to the US Healthcare Services industry average.

MYnd Analytics is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for MYnd Analytics, we can't assess if its growth is good value.


Price Based on Value of Assets

MYnd Analytics is overvalued based on assets compared to the US Healthcare Services industry average.


Next Steps

Future Growth

How is MYnd Analytics expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

13.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

MYnd Analytics's revenue is expected to grow significantly at over 20% yearly.

MYnd Analytics is not considered high growth as it is expected to be loss making for the next 1-3 years.

MYnd Analytics's revenue growth is expected to exceed the United States of America market average.

Unable to compare MYnd Analytics's earnings growth to the United States of America market average as it is expected to be loss making during the next 1-3 years.

Unable to compare MYnd Analytics's earnings growth to the low risk savings rate as it is expected to be loss making during the next 1-3 years.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if MYnd Analytics will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has MYnd Analytics performed over the past 5 years?

-14.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

MYnd Analytics does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare MYnd Analytics's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare MYnd Analytics's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if MYnd Analytics has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if MYnd Analytics has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if MYnd Analytics improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is MYnd Analytics's financial position?


Financial Position Analysis

MYnd Analytics's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

MYnd Analytics's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

MYnd Analytics's level of debt (119%) compared to net worth is high (greater than 40%).

MYnd Analytics had negative shareholder equity 5 years ago, it is now positive therefore their debt level has improved.


Balance Sheet

Low level of unsold assets.

Debt is covered by short term assets, assets are 2.5x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

MYnd Analytics has less than a year of cash runway based on current free cash flow.

MYnd Analytics has less than a year of cash runway if free cash flow continues to grow at historical rates of 47.2% each year.


Next Steps

Dividend

What is MYnd Analytics's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate MYnd Analytics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate MYnd Analytics's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as MYnd Analytics has not reported any payouts.

Unable to verify if MYnd Analytics's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as MYnd Analytics has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of MYnd Analytics's salary, the management and board of directors tenure and is there insider trading?

2.3yrs

Average management tenure


CEO

Patrick Herguth (46yo)

0.6yrs

Tenure

0

Mr. Patrick Herguth has been serves as the Chief Executive Officer and Director of MYnd Analytics, Inc. since December 12, 2018. Prior to joining MYnd Analytics, Mr. Herguth served as Chief Operating Offic ...


Management Age and Tenure

2.3yrs

Average Tenure

58yo

Average Age

The tenure for the MYnd Analytics management team is about average.


Board Age and Tenure

4.0yrs

Average Tenure

54yo

Average Age

The tenure for the MYnd Analytics board of directors is about average.


Insider Trading

More shares have been bought than sold by MYnd Analytics individual insiders in the past 3 months.


Recent Insider Transactions

BuyUS$250,80023 May 19
John Pappajohn
EntityIndividual
Role
Member of the Board of Directors
Director
Shares33,333.32
Max PriceUS$7.52
BuyUS$167,60015 Mar 19
John Pappajohn
EntityIndividual
Role
Member of the Board of Directors
Director
Shares16,666.66
Max PriceUS$10.06

Ownership Breakdown


Management Team

  • George Carpenter (60yo)

    President & Chief Innovation Officer

    • Tenure: 8.3yrs
    • Compensation: US$468.33k
  • Mike Darkoch (75yo)

    Consultant & Advisor

    • Tenure: 6.6yrs
    • Compensation: US$234.99k
  • Stephen Suffin

    Co-Founder

    • Tenure: 0yrs
  • Brian MacDonald (58yo)

    Co-Founder & CTO

    • Tenure: 0yrs
    • Compensation: US$377.70k
  • Patrick Herguth (46yo)

    CEO & Director

    • Tenure: 0.6yrs
  • Don D'Ambrosio (56yo)

    Chief Financial Officer

    • Tenure: 2.3yrs
    • Compensation: US$288.75k
  • Leila Colgan

    Vice President of Sales & Marketing

    • Tenure: 1.9yrs
  • Claire Ambrosio

    General Counsel & Secretary

    • Tenure: 0yrs

Board Members

  • John Pappajohn (90yo)

    Director

    • Tenure: 9.9yrs
    • Compensation: US$13.20k
  • Robin Smith (54yo)

    Chairman of the Board

    • Tenure: 3.9yrs
    • Compensation: US$644.70k
  • Peter Unanue (52yo)

    Director

    • Tenure: 1.8yrs
    • Compensation: US$13.20k
  • Patrick Herguth (46yo)

    CEO & Director

    • Tenure: 0.6yrs
  • Geoffrey Harris (57yo)

    Director

    • Tenure: 4yrs
    • Compensation: US$25.00k
  • Michal Votruba (54yo)

    Director

    • Tenure: 4yrs
    • Compensation: US$13.20k

Company Information

MYnd Analytics, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: MYnd Analytics, Inc.
  • Ticker: MYND
  • Exchange: NasdaqCM
  • Founded: 2000
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$14.860m
  • Shares outstanding: 12.70m
  • Website: https://www.myndanalytics.com

Number of Employees


Location

  • MYnd Analytics, Inc.
  • 26522 La Alameda
  • Suite 290
  • Mission Viejo
  • California
  • 92691
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MYNDNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDMar 2007
BBOTBST (Boerse-Stuttgart)YesCommon StockDEEURMar 2007

Biography

MYnd Analytics, Inc. operates as a predictive analytics company primarily in the United States. The company manages the delivery of telepsychiatry and telebehavioral health services through a network of ps ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/07/18 00:06
End of Day Share Price2019/07/17 00:00
Earnings2019/03/31
Annual Earnings2018/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.